Adrenal Cancer
Overview
Authors
Affiliations
Adrenal cancer is a rare neoplasm. Up to 1 in 1500 adrenal incidentalomas, however, may hide a carcinoma, which, if diagnosed late or left untreated, is associated with significant morbidity and mortality. Despite extensive investigation of the molecular mechanisms involved in adrenal carcinogenesis and significant improvements in diagnostic imaging, efforts to cure advanced adrenal cancer remain largely unsuccessful. This article reviews the recent advances in molecular understanding, clinical diagnosis, and treatment of adrenal cancer.
Causes of death in patients with malignant adrenal tumours: a population-based analysis.
Zheng Y, Ren S, Yan Z, Hu T, Feng Y, Wang D J Endocrinol Invest. 2025; .
PMID: 39992618 DOI: 10.1007/s40618-025-02555-y.
Mbouche L, Epoupa Ngalle F, Sando Z, Choukem S, Angwafo 3rd F Int J Surg Case Rep. 2020; 72:577-583.
PMID: 32698292 PMC: 7327872. DOI: 10.1016/j.ijscr.2020.05.097.
Adrenocortical carcinoma and pulmonary embolism from tumoral extension.
Shekhar S, Gubbi S, Papadakis G, Nilubol N, Hannah-Shmouni F Endocrinol Diabetes Metab Case Rep. 2019; 2019.
PMID: 31765326 PMC: 6893304. DOI: 10.1530/EDM-19-0095.
Aghamohammadzadeh N, Faraji A, Bozorgi F, Faraji I, Moghadaszadeh M Int J Hematol Oncol Stem Cell Res. 2014; 7(2):38-42.
PMID: 24505527 PMC: 3913141.
Adrenal incidentaloma: a case of carcinoma.
Ruotolo G, Ambrosio M, Caroleo P, Bonacci E, Condito A, Merante A Clin Interv Aging. 2010; 5:31-5.
PMID: 20396632 PMC: 2854049.